High plasma and urine c3a, c5a, c5b-9, Bb, and low plasma properdin levels were found to show alternative complement activation and correlate with disease activity in pauci-immune crescentic GN patients [12, 13]. The gene discussed is C5; the disease is ganglioneuroma.